company background image
PEPG

PepGen NasdaqGS:PEPG Stock Report

Last Price

US$15.38

Market Cap

US$363.5m

7D

-4.6%

1Y

n/a

Updated

04 Feb, 2023

Data

Company Financials +

PEPG Stock Overview

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.

PEPG fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

My Notes

New

Notes are coming soon

PepGen Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for PepGen
Historical stock prices
Current Share PriceUS$15.38
52 Week HighUS$17.81
52 Week LowUS$4.32
Beta0
1 Month Change4.06%
3 Month Change43.07%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO19.32%

Recent News & Updates

We Think PepGen (NASDAQ:PEPG) Can Afford To Drive Business Growth

Dec 31
We Think PepGen (NASDAQ:PEPG) Can Afford To Drive Business Growth

Recent updates

We Think PepGen (NASDAQ:PEPG) Can Afford To Drive Business Growth

Dec 31
We Think PepGen (NASDAQ:PEPG) Can Afford To Drive Business Growth

Here's Why We're Not Too Worried About PepGen's (NASDAQ:PEPG) Cash Burn Situation

Sep 07
Here's Why We're Not Too Worried About PepGen's (NASDAQ:PEPG) Cash Burn Situation

PepGen GAAP EPS of -$1.23 misses by $0.47

Aug 12

Shareholder Returns

PEPGUS BiotechsUS Market
7D-4.6%-0.8%1.7%
1Yn/a4.4%-9.6%

Return vs Industry: Insufficient data to determine how PEPG performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how PEPG performed against the US Market.

Price Volatility

Is PEPG's price volatile compared to industry and market?
PEPG volatility
PEPG Average Weekly Movement10.7%
Biotechs Industry Average Movement12.1%
Market Average Movement6.7%
10% most volatile stocks in US Market17.5%
10% least volatile stocks in US Market2.8%

Stable Share Price: PEPG is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: PEPG's weekly volatility has decreased from 23% to 11% over the past year.

About the Company

FoundedEmployeesCEOWebsite
201840James McArthurhttps://www.pepgen.com

PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company’s lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD.

PepGen Inc. Fundamentals Summary

How do PepGen's earnings and revenue compare to its market cap?
PEPG fundamental statistics
Market CapUS$363.46m
Earnings (TTM)-US$61.31m
Revenue (TTM)n/a

0.0x

P/S Ratio

-5.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
PEPG income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$61.31m
Earnings-US$61.31m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-2.59
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did PEPG perform over the long term?

See historical performance and comparison